7 ms·
Cancer breakthrough leads China’s biotech boom
- melling 9y agoAccording to the article, Chinese firms are making advances in chimeric antigen receptor cell therapy (Car-T) to treat cancer.
- Numberwang 9y agoI would love to be able to read this.
- evgen 9y agoThe people who spent the time and effort to do the research and write the story would like to get paid. Seems like there is a simple solution here...
- deleted 9y ago[deleted]
- hourislate 9y agohttp://archive.li/Oz6wb http://archive.li/Oz6wb
- hyperbovine 9y agoI count no fewer than eight options on the landing page that would enable you to read this.
- farresito 9y agohttps://outline.com/tdDNdd https://outline.com/tdDNdd
- stevemk14ebr 9y agoThis should be the article linked. Mods can you switch, the current one behind a subscription wall?
- dang 9y agoIt's ok to post workarounds in the threads, but we don't change the official URLs to those. Doing that would obscure the article source, among other reasons. https://news.ycombinator.com/newsfaq.html https://news.ycombinator.com/newsfaq.html https://news.ycombinator.com/item?id=10178989 https://news.ycombinator.com/item?id=10178989
- egeozcan 9y agoHi dang. I really do not understand why it is ok to post pay-walled articles. It makes the frontpage a minefield IMHO. Maybe a short reason can also be stated in the FAQ in addition to that being ok. BTW, is it also ok to post articles behind a registration-wall? I mean, like something shared on FB which can only be viewed by members?
- dang 9y agoIt's explained in the second link there as well as tons of comments I've posted about this (https://hn.algolia.com/?sort=byDate&dateRange=all&type=comment&storyText=false&prefix=false&page=0&query=by:dang%20paywalls https://hn.algolia.com/?sort=byDate&dateRange=all&type=comme...). We find the paywalls as annoying as anyone, but as long as there are publicly available workarounds, the articles remain accessible at the price of annoyance. This sucks, of course, but an HN without articles from any such publications would suck worse. Since the core idea of HN is to try to optimize for curiosity, we don't have much of a choice. Hopefully someday the publication problem will get a definitive solution and we won't have to deal with this crap anymore. In the meantime, publicly accessible workarounds are the best of a bad bunch. (Re registration sites, it's the same principle: if there's a publicly available workaround, it's ok, if not it's not.)
- hsljekskfh 9y agoyou know i actually think you’re right and something could be done. i literally always open the comments first because something like a quarter of articles here are paywalled and they always have a mirror by the time i read them. my system works and it seems like people don’t like your sentiment. but i don’t understand why.
- JacobJans 9y agohttps://www.outline.com/dmca.html https://www.outline.com/dmca.html
- ricksanch88 9y agoWell, I just found my new favorite extension.
- joshgel 9y agoPhysician here: CAR-T is a potentially amazing technology, but really only works in a small sub-set of the patients for which it is tried. For now
- beefman 9y agoMaybe if you tried it as a first-line treatment instead of on relapsed basket cases it'd work better.
- cryoshon 9y agoyeah, when i was working on CAR-T stuff a few years ago this was the thing we always said. most of the mouse models that we prove the therapies in (at least to start) are treatment-naive, which makes a difference.
- drjasonharrison 9y agoand mice are very poor substitutes for humans.
- aaavl2821 9y agoTox is very severe and the cost of drug plus managing the side effects is massively expensive. So the risk / benefit and health economics are worse in early stage cancer. They'll study it in earlier stage at some point probably
- mombul 9y agoNormal person here: why?
- josephv 9y agoBad reddit - why aren't physicians normal people?
- AnimalMuppet 9y ago
- starlord97 9y agoCan anyone explain how you go about re-engineering a cell to fight off cancer?
- clavalle 9y agohttps://weekly.biotechprimer.com/putting-the-car-t-before-the-horse/ https://weekly.biotechprimer.com/putting-the-car-t-before-th...
- zamalek 9y agoELI5: Your immune system fights cancerous cells frequently. There's only a problem when the cancerous cells evolve to avoid this by "hiding" (typically by no longer releasing a "kill me" marker). The therapy basically gives your immune system the tools to identify cancerous cells.
- deleted 9y ago[deleted]
- vibrio 9y agoT cells kill infected cells by detecting foreign proteins using a lock and key tube mechanism (Key = foreign antigen, Lock = T cell receptor). Normally any given T cell an its off spring have only one specificity of lock (although collectively there are many millions of locks in the body). CAR-T therapy is when they pull out a bunch of T cells for a patient and genetically modify the cell to have a know lock which is specific for a key known to be on the Cancer, then put them back into the patient. So, relatively, there is a massive increase in the frequency of T cell with that specificity in the patient, and hopefully they kill the tumor cells.
- jfarlow 9y agoCancer = you, but misregulated. Code for various tissues are turned on at 'incorrect' times, including code for profliferateNow(), ignoreAutoDestruct(), and can start running contradictory code like beNeuronLike() and beMuscleLike() simultaneously. T-Cells generally sense 'rogue' cells, and command them to auto-destruct. Many cancers are rendered invisible to your immune system because their presentation to the immune system is indistinguishable from a healthy cell in that it doesn't present any feature that is not found elsewhere in the body. In an engineered Car-T cell, an immune cell is reprogrammed by providing the cell with a DNA blueprint for a synthetically engineered protein called a 'Chimeric Antigen Receptor (CAR)'[1]. That engineered protein has two major functions - sense a particular cell type, and activate the T-cell to kill whatever triggers its sensor. The sensing mechanism is relatively arbitrary from an engineering perspective, so we engineer the sensor to sense a particular cell type which has become cancerous. And the attack trigger is a shortcut of the entire immunological activation pathway - skipping straight to sense->attack, bypassing the natural defenses to prevent autoimmune problems. Because the sensing mechanism of the synthetic protein is modular, these engineered proteins can swap out various 'sensors' to create new therapies relatively easily. Sense any cell that looks like a [lymphocyte/B-cell] and [kill it]. More sophistocated versions of these synthetic proteins can actually start to incorporate and-gates and other formal logic into their sensing capabilities: if(sense(neuron && muscle)){ killTarget(); } (where no neuron-like markers should ever show up with muscle-like markers except in a genetically scrambled cell, i.e. cancer). [1] https://serotiny.bio/notes/proteins/car19/ https://serotiny.bio/notes/proteins/car19/
- smaili 9y ago> Car-T is at the cutting edge of biology: it involves extracting a patient’s blood cells, re-engineering them in a lab so they can identify and destroy cancer and then re-inserting them into the body. It would be interesting to see if we could one day make this more optimal by reducing the extra step. Changing the above to: > Car-T is at the cutting edge of biology: it involves re-engineering a patient's blood cells in a lab so they can identify and destroy cancer in the body.
- AnimalMuppet 9y agoRe-engineering a patient's blood cells means first having a patient's blood cells. At some point, some cells have to be extracted for the cells to be available.
- yborg 9y agoThat would be cool, but also creepy if my blood cells can destroy cancer in my body while they're still in a lab. What if they start destroying cells in other people's bodies?
- ShabbosGoy 9y agoThat’s not how antigens work.
- jfarlow 9y agoThis is the end-goal. The delivery of synthetic genetic payloads in a live organism is still a bit tricky. Certain therapies do do this by injecting a synthetic 'virus' directly into your bloodstream. However, since it's so easy to extract T-cells, the risk of withdrawing blood, engineering it, & replacing it, it is worth the extra time to guarantee the delivery of the genetic payload is correct and thorough. As the sophistication of genetic delivery improves, direct delivery will absolutely become more common - and in fact will likely be a required technological step to curing harder-to-reach cancer and genetic abnormalities. That's why the first gene therapies are for the immunologically privileged, and easily accessible sites of the blood and the eye.
- thisisit 9y ago> But the most eye-catching research at last year’s conference was presented by a Chinese biotech group that virtually no one had heard of: Nanjing Legend. I don't mean to belittle this achievement but when will media learn that there are no "unheard" companies in China. Only those which have government backing and those which don't. While this an amazing story, I think it will be best to wait before pronouncing that there is a boom or not.
- riceonmars 9y agoYour second and third paragraphs have no relation to each other. The second paragraph comes from some tabloid about China. The third one just says “wait and see”
- desireco42 9y agoPaywall! Can't be that all of you are subscribed to FT?! Read here, maybe update original link: https://outline.com/tdDNdd https://outline.com/tdDNdd
- guardiangod 9y agoUnlike other medical trials involving chronic illness, cancer trials have a pretty clear indicator of whether the treatment is successful- (most) the patients survive longer than their prognosis. In this sense, there's not much freedom for the Chinese biofirms to commit fraud during a treatment trial. Everything is verifiable.
- JohnJamesRambo 9y agoWhy would falsifying that data be any harder? Don’t you just substitute patient lived for patient had less headaches or whatever?
- TheMagicHorsey 9y agoIts hard to fake that a dead person is still alive. Its easier to say that they reported no headaches.
- guardiangod 9y agoYou can always fudge your trial result. What I am saying is that the line between an effective treatment and an ineffective treatment is very clear- more patients are alive by the end of the trial. Versus, say, a test for a new antidepressant drugs, where being 'happier' is hard to quantify. Everything else is just record tracking.
- cannabisceo 9y agoThis isn't exactly true. People with cancer often have comorbidities that are 'competing events' and survival does not always tell the full story. I published about this topic and it's more complex and subtle than you would think. https://www.mailman.columbia.edu/research/population-health-methods/competing-risk-analysis https://www.mailman.columbia.edu/research/population-health-...
- ilamont 9y ago"80% of China’s clinical trial data are fraudulent, investigation finds" ust over 80% of clinical trial data submitted to support new drug registrations in China have been revealed as fraudulent or substandard by the country’s drug regulator. An investigation of data for 1622 new drugs submitted to China’s State Food and Drug Administration (CFDA) for registration said that 1308 of the applications should be withdrawn because they contained fabricated, flawed, or inadequate data from clinical trials.1 In a damning report released on 9 September the CFDA described the findings of widespread fraud as shocking and vowed to crack down on what it described as a “chaotic” situation in the country’s clinical trials industry. Much of the blame was attributed to the country’s loosely regulated clinical research organisations, which industry insiders claimed operate in … https://www.bmj.com/content/355/bmj.i5396 https://www.bmj.com/content/355/bmj.i5396
- bitrazor123 9y agoWhat will happen to american drug cartel now? FOr that matter china would be having its own drug and animal-organ-drug cartel.
- polskibus 9y agoI wonder if a similar technique to car-t could be deployed to fight off autoimmune diseases?
- rdiddly 9y agoSighhh... apparently they can't just report on a story from China without peppering it with statements about the US -- specifically about how this is a new salvo in some kind of healthcare war with the US. Sometimes stuff just happens when people do things. They're probably not pushing to advance healthcare just to fuck with the US. Some made-up headlines from world history written from this incredibly narcissistic viewpoint: Pharaoh to Build Great Pyramid, Challenging Structure-Building Dominance of Future Country "America" Scientist Marie Curie Discovers "Radioactivity" in Effort to Humiliate USA In Rare Reversal, Da Vinci's "Mona Lisa" Better Than Similar American Art Works
- hsljekskfh 9y agothanks for making your point with humor, it’s underused on hn. i agree with the sentiment too
- car 9y agoAn outgrowth of American exceptionalism.
- ixtli 9y agoNot to say that they're by any means perfect, but I think what you've pointed out might help explain why many Americans i grew up around see the Chinese government as some sinister and inscrutable entity that is out to silently crush everyone. Also, you don't need to make up fake examples when you can look up anything in the past year about how they're making big strides towards reversing their smog problems and how that's somehow an attack on American industry. Even trump has made these claims ( https://lh6.googleusercontent.com/uDFmIDPzCo4znxgzKlT0_jgv4CqHkarUrQ005ED_HbclD4Ex32hmOHsAn95kbFc_WZMiOQ1BMlRj4Fu-vDLyOgnT3syuxfWFY8KxoEWpqd9gxcPzZnQUM8q76jkJzs7IQUNr_cUt https://lh6.googleusercontent.com/uDFmIDPzCo4znxgzKlT0_jgv4C... )
- specialist 9y agoYounger me was a news junkie. Iran hostage crisis, USSR was gonna nuke us, Japan was going to buy us, etc. Of course, I believed it all. Over time, I noticed shit just didn’t add up. And no one did a mea culpa. So I just stopped listening. I figure all ad supported news media is ghouls profiting from human misery, stoking fear and anxiety to keep people numb, allowing the real outrages to happen unnoticed. (eg Project Censored) I hope China continues to do well. Ditto everyone. We all do better when we all do better.
- bastijn 9y agoThis might happen more often in the near future. Whilst medical innovations are booming due to the introduction of cheap options to run machine learning the regulatory units are not keeping up. Getting FDA approvals is a long process but required before they let you enter the US market. EU is easier but soon they will put in place a new regulatory unit that is said to be even more restrictive than the FDA. When that happens it may very well be the Asian countries, China being a good option, India another, that take the lead when it comes to innovation in the medical world.
- txsh 9y agoThis would be great if it were true. Unfortunately, it’s a clinical trial from China.
- blackrock 9y ago> A few days before Craig Chase was discharged from the Jiangsu Provincial People’s Hospital in Nanjing, his doctor told him something he never expected to hear: his cancer had been cured. > “His English was not so good, so he used Google Translate. When he said I was cured, I told him it was impossible — there is no cure for multiple myeloma,” he recalls. “But he said, ‘no, you’re definitely cured’. It was unbelievable.” > Unbelievable, perhaps, but also true. When Mr Chase, now 57, returned home to America after his six weeks of treatment in China to undergo further tests, his doctors could find no trace of multiple myeloma. The blood cancer he had suffered for three years — which had threatened to end his life — was gone. This is incredible! If they can figure out how to cure cancer, then how will the pharmaceutical companies make money? This sounds like a diabolical plan for.. Lex Luthor! Lex: "Destroy the cure. Instead, make a drug treatment plan, that the patient must take every week, for the rest of their life."
- wemdyjreichert 9y agoPaywall.